Cart
sales@molnova.com
R162
CAS No. 64302-87-0
R162( R162 | R 162 | R-162 )
Catalog No. M17560 CAS No. 64302-87-0
R162 is an effective glutamate dehydrogenase 1 (GDH1) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 69 | In Stock |
|
| 10MG | 123 | In Stock |
|
| 25MG | 267 | In Stock |
|
| 50MG | 428 | In Stock |
|
| 100MG | 610 | In Stock |
|
| 500MG | 1242 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameR162
-
NoteResearch use only, not for human use.
-
Brief DescriptionR162 is an effective glutamate dehydrogenase 1 (GDH1) inhibitor.
-
DescriptionR162 is an inhibitor of GDH activity and represses glioma cell growth.
-
In Vitro——
-
In Vivo——
-
SynonymsR162 | R 162 | R-162
-
PathwayAngiogenesis
-
TargetEGFR
-
Recptorglutamate dehydrogenase 1 (GDH1)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number64302-87-0
-
Formula Weight264.28
-
Molecular FormulaC17H12O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL; 378.39 mM
-
SMILESO=C(C1=C2C=CC=C1)C3=CC=C(CC=C)C(O)=C3C2=O
-
Chemical Name2-Allyl-1-hydroxy-anthraquinone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jin L, et al. Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer Cell. 2015 Feb 9;27(2):257-70.
molnova catalog
related products
-
Olmutinib
Olmutinib is a Novel Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorOlmutinib at 3 μM significantly reversed drug resistance mediated by ABCG2, but not by ABCB1 and ABCC1, by antagonizing the drug efflux function in ABCG2-overexpressing cells.?
-
BMS-599626
A potent, selective inhibitor of EGFR and HER2 with IC50 of 20 nM and 30 nM.
-
Tiotropium Bromide h...
Tiotropium Bromide hydrate is a monohydrate of tiotropium bromide (Spiriva; Tiova; BA 679BR; tiopropium) that is an anticholinergic and bronchodilator and a muscarinic receptor antagonist.
